GTCR, a leading private equity firm, announced today that its management partnership with Gregory T. Lucier, Corza Health, has simultaneously acquired and merged Surgical Specialties Corporation (“Surgical Specialties”) and the TachoSil® Fibrin Sealant Patch (“TachoSil”) to create a new company, Corza Medical. Surgical Specialties is a medical technology company focused on high-performance surgical sutures and ophthalmic knives. TachoSil, previously owned by Takeda Pharmaceutical Company Limited, is a differentiated surgical patch product line used to enable safe and fast bleeding control during surgeries.
Read the full article: GTCR and Gregory T. Lucier Announce Merger of Surgical Specialties and TachoSil to Create Corza Medical //
Source: https://www.prnewswire.com/news-releases/gtcr-and-gregory-t-lucier-announce-merger-of-surgical-specialties-and-tachosil-to-create-corza-medical-301218913.html